Managing Director’s End of Year Message 2024 2024 Announcements . Corporate . News . Regulatory 23.12.2024
Health Canada validates SCENESSE® New Drug Submission 2024 Announcements . Corporate . News . Regulatory 23.12.2024
Appendix 3H — Notification of cessation of securities 2024 Announcements . Financial . News . Regulatory 04.12.2024
SCENESSE® dosage expansion under review by European Medicines Agency 2024 Announcements . Clinical . News . Regulatory 20.11.2024
CLINUVEL prioritises three strategic programs 2024 Announcements . Clinical . News . Regulatory 18.11.2024
Appendix 3Z – Final Director’s Interest Notice 2024 Announcements . Financial . News . Regulatory 17.10.2024